A Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya
MAMMS IYCF R33
A Mixed Methods Randomized Controlled Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya
2 other identifiers
interventional
600
1 country
2
Brief Summary
The goal of this study is to test if a two-way text-message (SMS) maternally administered malnutrition monitoring system (MAMMS) that delivers infant and young child feeding (IYCF) education and supports caregivers in monitoring their child's nutritional status at home can improve nutritional outcomes for HIV-exposed children. The aims include 1) to determine whether the MAMMS IYCF intervention lowers the incidence of malnutrition, leads to a shorter time to recover for those that become malnourished and results in a lower incidence of hospitalizations, severe malnutrition and death, 2) to determine the cost and cost-effectiveness of the MAMMS IYCF intervention, and 3) to determine the effect of the MAMMS IYCF intervention on the behavior and attitudes of participants through change in age-appropriate feeding, IYCF knowledge, trust in the healthcare system, and intention to seek care if the child becomes wasted. The study team will enroll 600 caregiver-child pairs aged between 6 and 24 months in Migori and Homa Bay County, Kenya. Each caregiver-child pair will be randomly assigned to either the MAMMS IYCF intervention or standard of care (SOC) and followed for 180 days (about 6 months). Caregivers assigned to the intervention arm will be asked to respond to weekly messages with the color of the MUAC tape after measuring their child's arm after being trained on how to use the MUAC measuring tape. Weekly messages will include IYCF education and other age-appropriate child health related information. Caregivers in the SOC arm will receive clinic appointment and study visit reminders only. Caregivers in the intervention arm and the SOC arm will be asked to attend the study clinic for follow-up visits at Day 90 and Day 180. At enrollment and follow-up visits, the study team will administer a survey including a child's medical history, a standardized child clinical examination, and anthropometry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2025
CompletedFirst Posted
Study publicly available on registry
February 24, 2025
CompletedStudy Start
First participant enrolled
June 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
May 4, 2026
April 1, 2026
1.9 years
February 18, 2025
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Children randomized to MAMMS-IYCF will have a lower incidence of wasting, and shorter duration of wasting treatment due to early initiation of treatment.
Assessed by measuring the incidence of healthcare worker confirmed wasting (weight-for-height z-score \<-2, nutritional edema, or MUAC \<12.5 cm for children ≥6-months of age)
From enrollment to the end of follow-up at 180 days
Secondary Outcomes (6)
The MAMMS-IYCF arm will have fewer hospitalizations compared to the SOC arm
From enrollment to the end of follow up at 180 days
The MAMMS-IYCF arm will have fewer deaths compared to the SOC arm
From enrollment to the end of follow up at 180 days
The MAMMS-IYCF arm will have fewer cases of severe wasting compared to the SOC arm
From enrollment to the end of follow up at 180 days
MAMMS-IYCF will be lower cost and more cost-effective from both provider and societal perspectives
From enrollment to the end of follow up at 180 days
Number of caregivers reporting their child received age appropriate feeding as defined by WHO at each study visit will be higher in the MAMMS IYCF arm compared to the SOC arm
From enrollment to the end of follow up at 180 days
- +1 more secondary outcomes
Study Arms (2)
MAMMS IYCF intervention arm
EXPERIMENTALAll caregivers randomized to the MAMMS-IYCF arm will be given two MUAC tapes after being trained by skilled study staff and their contact information will be entered into the online MAMMS-IYCF platform. The frequency of messages will be weekly. This will be a two-way SMS system, including health messages on age appropriate IYCF. These messages will also prompt caregivers to measure their child's MUAC, return the color outcome of the measurement to the clinic via the SMS system, and they will also be able to ask any health questions that they may have through the SMS. During follow-up, any caregiver who returns a MUAC measurement via SMS that suggests their child is wasted, will receive an SMS response asking them to come to the clinic with their child as soon as possible. At this visit, the wasting status of the child will be confirmed by a study staff, and if treatment is indicated they will be enrolled into nutritional care provided by MOH nutritionists.
Standard of care (control) arm
ACTIVE COMPARATORTo promote high fidelity to current guidelines, all families randomized to the SOC arm will be enrolled into a one-way SMS service that will send them automated reminders before necessary routine EID or HIV care visits and research clinic appointments on day 90 and 180. During these routine clinic visits, study staff will ensure that the MUAC of SOC children are measured, and that treating clinicians (MOH nutritionists) are made aware if wasting is identified. Staff will ensure that SOC children are enrolled into nutritional care if they are wasted. This additional support means it is likely that SOC children in this study will receive care that is more adherent to current recommendations than is typical for many children. This enhanced SOC is necessary to ensure we are comparing the MAMMS-IYCF to current guidelines. The SMS messaging service will be free of cost to the caregivers as they will not incur any charges to send or receive messages while enrolled in the trial.
Interventions
To promote high fidelity to current guidelines, all families randomized to the SOC arm will be enrolled into a one-way SMS service that will send them automated reminders before necessary routine EID or HIV care visits and research clinic appointments on day 90 and 180. During these routine clinic visits, study staff will ensure that the MUAC of SOC children are measured, and that treating clinicians (MOH nutritionists) are made aware if wasting is identified. Staff will ensure that SOC children are enrolled into nutritional care if they are wasted. This additional support means it is likely that SOC children in this study will receive care that is more adherent to current recommendations than is typical for many children. This enhanced SOC is necessary to ensure we are comparing the MAMMS-IYCF to current guidelines. The SMS messaging service will be free of cost to the caregivers as they will not incur any charges to send or receive messages while enrolled in the trial.
All caregivers randomized to the MAMMS-IYCF arm will be given two MUAC tapes after being trained by skilled study staff and their contact information will be entered into the online MAMMS-IYCF platform. The frequency of messages will be weekly. This will be a two-way SMS system, including health messages on age appropriate IYCF. These messages will also prompt caregivers to measure their child's MUAC, return the color outcome of the measurement to the clinic via the SMS system, and they will also be able to ask any health questions that they may have through the SMS. During follow-up, any caregiver who returns a MUAC measurement via SMS that suggests their child is wasted, will receive an SMS response asking them to come to the clinic with their child as soon as possible. At this visit, the wasting status of the child will be confirmed by a study staff, and if treatment is indicated they will be enrolled into nutritional care provided by MOH nutritionists.
Eligibility Criteria
You may qualify if:
- Children aged 6 to 24 months all-inclusive with a MUAC ≥ 12.5cm at the date of recruitment
- Children living with HIV or HIV-exposed uninfected children seen as outpatients in early infant detection (EID) or HIV-care clinics at the participating hospitals
- The child's caregiver is willing and able to provide informed consent
- The child's caregiver can read or write or has someone to help them read or write
- The child's caregiver is planning to remain in the catchment area with their child for \> 6 months and willing to return to the health facility for 6-month follow up visits
- The child's caregiver has access to a Safaricom phone line and provides a mobile phone number
- \- Healthcare workers working in Homa Bay and Migori County Referral Hospitals, who have contact with pediatric inpatients
You may not qualify if:
- Children with moderate or severe wasting (MUAC \<12.5cm, weight-for-height z-score \<-2, or nutritional edema) at the time of eligibility screening
- Children with a congenital condition that limit feeding or syndromes that prevents age-appropriate feeding
- Child is enrolled in another study that the PI judges to compromise the aims of this study
- Child's caregiver does not pass the second training after being unable to satisfactorily complete the first MUAC training.
- Child's caregiver is under the age of 18 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Homa Bay County Referral Hospital
Homa Bay, Kenya
Migori County Referral Hospital
Migori, Kenya
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arianna R Means, PhD
University of Washington
- PRINCIPAL INVESTIGATOR
Kirkby Tickell, PhD
University of Washington
- PRINCIPAL INVESTIGATOR
Benson Singa, PhD
Kenya Medical Research Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor: School of Medicine, Global Health
Study Record Dates
First Submitted
February 18, 2025
First Posted
February 24, 2025
Study Start
June 5, 2025
Primary Completion (Estimated)
May 5, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
De-identified IPD collected throughout the trial may be shared with other researchers within approximately 6 months of results publication